1
|
Kataoka M, Lee TL, Sawai T. Human Brain Organoid Research and Applications: Where and How to Meet Legal Challenges? JOURNAL OF BIOETHICAL INQUIRY 2024:10.1007/s11673-024-10349-9. [PMID: 38969917 DOI: 10.1007/s11673-024-10349-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Accepted: 02/23/2024] [Indexed: 07/07/2024]
Abstract
An ethical and legal framework is needed to regulate the rapidly developing human brain organoid research field properly. However, considering the legal issues involved in human brain organoid research remains underdeveloped and scattered. This article reviews the legal issues of human brain organoid research, grouping them into the following five broad themes: (1) consciousness, (2) legal status, (3) consent, (4) ownership, and (5) transplantation. The issues in each topic include both the urgent (e.g., appropriate forms of consent) and the speculative (e.g., protection of conscious human brain organoids). Therefore, we have attempted to be as explicit as possible about the timescale within which each issue will be realized and to prioritize each. Examining these issues has revealed legal issues specific to human brain organoid research and issues common to research in other fields. Further discussion of human brain organoid research from a legal perspective is needed in the future, considering discussions in related fields.
Collapse
Affiliation(s)
- M Kataoka
- Graduate School of Humanities and Social Sciences, Hiroshima University, Higashi-Hiroshima, Japan
| | - T-L Lee
- Graduate Institute of Health and Biotechnology Law, Taipei Medical University, Taipei, Taiwan
| | - T Sawai
- Graduate School of Humanities and Social Sciences, Hiroshima University, Higashi-Hiroshima, Japan.
- Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
- Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
| |
Collapse
|
2
|
Ko J, Hyung S, Cheong S, Chung Y, Li Jeon N. Revealing the clinical potential of high-resolution organoids. Adv Drug Deliv Rev 2024; 207:115202. [PMID: 38336091 DOI: 10.1016/j.addr.2024.115202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 01/01/2024] [Accepted: 02/02/2024] [Indexed: 02/12/2024]
Abstract
The symbiotic interplay of organoid technology and advanced imaging strategies yields innovative breakthroughs in research and clinical applications. Organoids, intricate three-dimensional cell cultures derived from pluripotent or adult stem/progenitor cells, have emerged as potent tools for in vitro modeling, reflecting in vivo organs and advancing our grasp of tissue physiology and disease. Concurrently, advanced imaging technologies such as confocal, light-sheet, and two-photon microscopy ignite fresh explorations, uncovering rich organoid information. Combined with advanced imaging technologies and the power of artificial intelligence, organoids provide new insights that bridge experimental models and real-world clinical scenarios. This review explores exemplary research that embodies this technological synergy and how organoids reshape personalized medicine and therapeutics.
Collapse
Affiliation(s)
- Jihoon Ko
- Department of BioNano Technology, Gachon University, Gyeonggi 13120, Republic of Korea
| | - Sujin Hyung
- Precision Medicine Research Institute, Samsung Medical Center, Seoul 08826, Republic of Korea; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul 08826, Republic of Korea
| | - Sunghun Cheong
- Interdisciplinary Program in Bioengineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| | - Yoojin Chung
- Division of Computer Engineering, Hankuk University of Foreign Studies, Yongin 17035, Republic of Korea
| | - Noo Li Jeon
- Interdisciplinary Program in Bioengineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea; Department of Mechanical Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea; Institute of Advanced Machines and Design, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea; Qureator, Inc., San Diego, CA, USA.
| |
Collapse
|
3
|
Pichl A, Ranisch R, Altinok OA, Antonakaki M, Barnhart AJ, Bassil K, Boyd JL, Chinaia AA, Diner S, Gaillard M, Greely HT, Jowitt J, Kreitmair K, Lawrence D, Lee TN, McKeown A, Sachdev V, Schicktanz S, Sugarman J, Trettenbach K, Wiese L, Wolff H, Árnason G. Ethical, legal and social aspects of human cerebral organoids and their governance in Germany, the United Kingdom and the United States. Front Cell Dev Biol 2023; 11:1194706. [PMID: 38020890 PMCID: PMC10679683 DOI: 10.3389/fcell.2023.1194706] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Accepted: 10/27/2023] [Indexed: 12/01/2023] Open
Abstract
Human cerebral organoids (HCOs) are model systems that enable researchers to investigate the human brain in ways that had previously been impossible. The emergence of HCOs was accompanied by both expert and layperson discussions concerning the possibility of these novel entities developing sentience or consciousness. Such concerns are reflected in deliberations about how to handle and regulate their use. This perspective article resulted from an international and interdisciplinary research retreat "Ethical, Legal and Social Aspects of Human Cerebral Organoids and their Governance in Germany, the United Kingdom and the United States", which took place in Tübingen, Germany, in August 2022. The retreat focused on whether HCO research requires new ethical and regulatory approaches. It addressed epistemic issues around the detection and theorisation of consciousness, ethical concerns around moral status and research conduct, difficulties for legislation and guidelines managing these entities, and public engagement.
Collapse
Affiliation(s)
- Anja Pichl
- Faculty of Health Sciences Brandenburg, University of Potsdam, Germany
- Research Unit “Ethics of Genome Editing”, Institute of Ethics and History of Medicine, The University of Tübingen, Tübingen, Germany
| | - Robert Ranisch
- Faculty of Health Sciences Brandenburg, University of Potsdam, Germany
- Research Unit “Ethics of Genome Editing”, Institute of Ethics and History of Medicine, The University of Tübingen, Tübingen, Germany
| | - Ozan Altan Altinok
- Center for Ethics and Law in the Life Sciences, University of Hannover, Hannover, Germany
| | - Melpomeni Antonakaki
- Department of Science, Technology and Society, Technical University Munich, Munich, Germany
| | | | - Katherine Bassil
- Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands
| | - J. Lomax Boyd
- Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, United States
| | | | - Sarah Diner
- Institute for Medical Humanities, Medical Faculty, University of Bonn, Bonn, Germany
| | - Maxence Gaillard
- HYBRIDA Project, University of Oslo, Oslo, Norway and UCLouvain, Louvain-la-Neuve, Belgium
| | - Henry T. Greely
- Stanford Law School, Stanford University, Stanford, CA, United States
| | - Joshua Jowitt
- Newcastle Law School, Newcastle University, Newcastle, United Kingdom
| | - Karola Kreitmair
- Department of Medical History and Bioethics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States
| | - David Lawrence
- Durham Law School, Durham University, Durham, United Kingdom
| | - Tim Nicholas Lee
- Edinburgh Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom
| | - Alex McKeown
- Department of Psychiatry, Wellcome Centre for Ethics and Humanities, University of Oxford, United Kingdom
| | - Vorathep Sachdev
- Edinburgh Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom
| | - Silke Schicktanz
- Institute of Medical Ethics and History of Medicine, University Medical Center Göttingen, Göttingen, Germany
| | - Jeremy Sugarman
- Berman Institute of Bioethics and Department of Medicine, Johns Hopkins University, Baltimore, MD, United States
| | - Katharina Trettenbach
- Faculty of Health Sciences Brandenburg, University of Potsdam, Germany
- Research Unit “Ethics of Genome Editing”, Institute of Ethics and History of Medicine, The University of Tübingen, Tübingen, Germany
| | - Lara Wiese
- Institute for Social and Health Law, Ruhr University Bochum, Bochum, Germany
| | - Hannes Wolff
- Chair of Constitutional and Administrative Law, Public International Law, European and International Economic Law, Faculty of Law, University of Passau, Passau, Germany
| | - Garðar Árnason
- Research Unit “Ethics of Genome Editing”, Institute of Ethics and History of Medicine, The University of Tübingen, Tübingen, Germany
- School of Humanities and Social Sciences, University of Akureyri, Akureyri, Iceland
| |
Collapse
|